Loading, please wait ...

News Analytics

shutterstock 234586750 jpg?w=1200&h=630&crop=1.
On Wednesday, June 15, the Senate Committee on Health, Education, Labor and Pensions advanced its version of the must-pass Food and Drug Administration (FDA) user fee reauthorization bill. Previously, I had reviewed several key similarities and differences between the Senate and House bills, with a focus on their impact on reforms to the prescription drug approval process.

The Angle

Subject Matter

  • Politics 39.47%
    • Domestic politics 100.00%
  • Healthcare 36.84%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 23.68%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.